Drugs Made in America AcquisDMIIU
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 30 institutions reported holding Drugs Made in America Acquis (DMIIU) in their 13F filings, down 45 from Q3 2025. 6 opened new positions and 14 sold out. The largest holders were MMCAP International Inc. SPC ($27.0M), LMR Partners LLP ($20.0M) and Healthcare of Ontario Pension Plan Trust Fund ($20.0M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Drugs Made in America Acquis
- CUSIP
- G2851K120
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.5M |
| Exits | 14 | $24.6M |
All 13F filers, Q3 2025 → Q4 2025: 639,307 shares bought and 4,959,300 shares sold, net −4,319,993 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| MMCAP International Inc. SPC | 2.75% | No change | 2,700,000 | $27.0M |
| LMR Partners LLP | 0.26% | No change | 2,000,000 | $20.0M |
| Healthcare of Ontario Pension Plan Trust Fund | 0.03% | No change | 2,000,000 | $20.0M |
| Heights Capital Management, Inc. | 1.99% | No change | 519,400 | $5.2M |
| Westchester Capital Management, LLC | 0.24% | Add +151.5% | 502,914 | $5.0M |
| TIG Advisors, LLC | 0.24% | No change | 500,000 | $5.0M |
| Millennium Management | 0.00% | Reduce -75.0% | 500,000 | $5.0M |
| Rivernorth Capital Management, LLC | 0.19% | No change | 400,000 | $4.0M |
| Steadfast Capital Management LP | 0.05% | No change | 300,000 | $3.0M |
| BlueCrest Capital Management Ltd | 0.11% | No change | 250,000 | $2.5M |
| Verition Fund Management LLC | 0.01% | Reduce -44.4% | 250,000 | $2.5M |
| Clear Street Group Inc. | 0.01% | Reduce -33.8% | 236,432 | $2.4M |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 0.27% | Add +15.2% | 179,500 | $1.8M |
| Gabelli Funds LLC | 0.01% | Add +18.3% | 161,400 | $1.6M |
| HRT Financial LP | 0.00% | Add +36.6% | 136,560 | $1.4M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -12.7% | 113,527 | $1.1M |
| L1 Global Manager Pty Ltd | 0.66% | — | 100,000 | $1.0M |
| Readystate Asset Management LP | 0.08% | No change | 100,000 | $1.0M |
| Centiva Capital, LP | 0.06% | No change | 100,000 | $1.0M |
| Walleye Capital LLC | 0.01% | No change | 100,000 | $1.0M |
| UBS Group AG | 0.00% | New | 93,470 | $936K |
| Parallax Volatility Advisers, L.P. | 0.03% | Reduce -76.0% | 89,079 | $892K |
| Stoic Point Capital Management LLC | 0.43% | — | 50,000 | $501K |
| Prelude Capital Management, LLC | 0.04% | New | 50,000 | $501K |
| PenderFund Capital Management Ltd. | 0.19% | Reduce -27.4% | 49,700 | $497K |
| Rangeley Capital, LLC | 0.28% | New | 32,551 | $326K |
| Susquehanna International Group, LLP | 0.00% | New | 25,112 | $251K |
| Boothbay Fund Management, LLC | 0.01% | New | 25,000 | $250K |
| Robinson Capital Management, LLC | 0.11% | New | 25,000 | $250K |
| Toronto Dominion Bank | 0.00% | Reduce -99.8% | 544 | $5K |
"% of holder's portfolio" is DMIIU's weight in each manager's 13F, not the share of Drugs Made in America Acquis the manager owns.